Hinge Health (NYSE:HNGE) Director Kristina Leslie Sells 1,200 Shares

Hinge Health Inc. (NYSE:HNGE) Director Kristina Leslie sold 1,200 shares of the firm’s stock in a transaction dated Thursday, August 20th. The stock was sold at an average price of $88.23, for a total value of $105,876.00. Following the transaction, the director owned 30,387 shares of the company’s stock, valued at $2,681,045.01. This trade represents a 3.80% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Hinge Health Trading Up 3.3%

NYSE:HNGE traded up $2.82 on Friday, reaching $88.44. 1,420,005 shares of the stock traded hands, compared to its average volume of 1,525,836. The company’s 50 day moving average is $80.94 and its 200-day moving average is $58.07. Hinge Health Inc. has a 1-year low of $30.08 and a 1-year high of $93.13. The firm has a market capitalization of $7.14 billion, a price-to-earnings ratio of 69.09 and a beta of 1.30.

Hinge Health (NYSE:HNGE) last posted its quarterly earnings data on Tuesday, August 4th. The company reported $0.59 earnings per share for the quarter, topping the consensus estimate of $0.28 by $0.31. The company had revenue of $212.82 million during the quarter. Hinge Health had a net margin of 15.15% and a return on equity of 51.60%. The company’s quarterly revenue was up 53.0% compared to the same quarter last year. During the same quarter last year, the company earned $0.59 earnings per share. On average, equities research analysts forecast that Hinge Health Inc. will post 1.25 EPS for the current fiscal year.

Institutional Trading of Hinge Health

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Nykredit A S purchased a new position in shares of Hinge Health during the second quarter valued at approximately $29,000. Comprehensive Financial Management LLC purchased a new stake in Hinge Health in the 2nd quarter valued at $212,000. Wellington Management Group LLP lifted its stake in Hinge Health by 169.7% during the 2nd quarter. Wellington Management Group LLP now owns 1,205,584 shares of the company’s stock valued at $100,063,000 after acquiring an additional 758,594 shares in the last quarter. 11.2 Capital Management LLC purchased a new position in Hinge Health during the 2nd quarter worth $204,566,531,000. Finally, Summit Creek Advisors LLC bought a new stake in shares of Hinge Health in the 2nd quarter worth $4,972,000.

Wall Street Analyst Weigh In

Several analysts have recently commented on the company. Morgan Stanley raised their target price on Hinge Health from $72.00 to $108.00 and gave the company an “overweight” rating in a research note on Monday, July 13th. Evercore reiterated an “outperform” rating and issued a $105.00 price target on shares of Hinge Health in a report on Wednesday, August 5th. Royal Bank Of Canada boosted their price objective on Hinge Health from $75.00 to $110.00 and gave the company an “outperform” rating in a report on Wednesday, August 5th. Wall Street Zen lowered Hinge Health from a “buy” rating to a “hold” rating in a research report on Saturday, August 8th. Finally, KeyCorp lifted their price target on shares of Hinge Health from $90.00 to $125.00 and gave the company an “overweight” rating in a research report on Monday, July 13th. One research analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $100.57.

Hinge Health Company Profile

Hinge Health (NYSE: HNGE) is a digital musculoskeletal (MSK) clinic that provides end-to-end solutions for the prevention and management of musculoskeletal conditions. The company’s platform combines wearable motion sensors, personalized exercise therapy guided by licensed physical therapists, and behavioral health coaching to deliver tailored treatment plans. By integrating technology with evidence-based clinical protocols, Hinge Health aims to reduce pain, improve mobility and decrease reliance on more invasive interventions such as surgery or opioid prescriptions.

Founded in 2015 and headquartered in San Francisco, Hinge Health partners with employers, health plans and other payers to offer its self-directed, app-based programs.